The Cardiac Insufficiency BIsoprolol Study in Japanese Patients with Chronic Heart Failure
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2019
Price : $35 *
At a glance
- Drugs Bisoprolol (Primary) ; Carvedilol (Primary)
- Indications Chronic heart failure; Dilated cardiomyopathy; Ischaemic heart disorders
- Focus Adverse reactions
- Acronyms CIBIS-J
- 06 Apr 2019 Primary endpoint (Tolerability: The probability that administered maintenance dose reaches the maximum (bisoprolol 5 mg/day, carvedilol 20 mg/day)) has not been met as per results published in the Circulation Journal.
- 06 Apr 2019 Results published in the Circulation Journal
- 30 Jan 2017 Status changed from active, no longer recruiting to completed.